2015 New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearch’s new seven-country report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the global coagulation testing market during the next five years.
The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
France, Germany, Italy, Japan, Spain, UK, USA
Worldwide Market Overview
- Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliersby country. - Estimated universe of facilities performing coagulation testsby country. - Five-year test volume and sales projections by country.
Business Opportunities and Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal. - Ideal product models with tentativeprices and operating characteristics. - Alternative market penetrationstrategies for instrument and reagent suppliers. - Potential market entry barriers and risks.
Current and Emerging Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance,Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis of Instrument and Reagent Suppliers
- Sales and market shares of major instrument and consumable manufactures by country.
- Test volume forecasts for over 40 major procedures,by country and market segment.
Current and Emerging Products
- Review of established and new procedures. - Comparison of automated and semi-automatedanalyzers marketed by Diagnostica Stago, Helena, IL,Roche, Siemens, Sysmex and other suppliers.
- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developingor marketing new technologies and products by test.
- Strategic assessments ofmajor suppliers and start-up firms developing innovative coagulation testing technologies and products, including their sales, product portfolios,marketing tactics, collaborative arrangements, and new products in R&D.